NeuroOne Medical Technologies Co. (NASDAQ:NMTC – Get Rating) was the recipient of a large decline in short interest in the month of March. As of March 15th, there was short interest totalling 36,500 shares, a decline of 66.2% from the February 28th total of 108,000 shares. Approximately 0.3% of the company’s shares are sold short. […]
NeuroOne Medical Technologies Co. (NASDAQ:NMTC – Get Rating) Director Mark Christianson sold 12,711 shares of the company’s stock in a transaction on Thursday, March 23rd. The stock was sold at an average price of $1.50, for a total value of $19,066.50. Following the completion of the sale, the director now owns 337,494 shares of the […]
Should You Buy or Sell NeuroOne Medical Technologies Stock? Get The Latest NMTC Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.